Type |
Details |
Score |
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hcls1/Hcls1 |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hcls1/Hcls1 |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
involves: 129S4/SvJae |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
involves: 129S1/Sv |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
B6.129S4-Lyn |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
involves: 129S4/SvJaeSor |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
involves: 129S4/SvJaeSor * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
C57BL/6JAnu-Lyn |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
C57B/6JAnu-Lyn/AnuApb |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hcls1/Hcls1 |
Background: |
C57BL/6NCrl-Hcls1/Ccpcz |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
C57BL/6N-Lyn/H |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn |
Background: |
involves: 129S4/SvJaeSor * C57BL/6J |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Allele |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 8, Shinichi Aizawa |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd22/Cd22<+> Lyn/Lyn<+> Tg(IghelMD4)4Ccg/? |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Il5ra/Il5ra Lyn/Lyn |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hcls1/Hcls1 Tg(TcraH-Y,TcrbH-Y)71Vbo/? |
Background: |
involves: 129P2/OlaHsd * C57BL/6J * DBA/2J |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn Mpl/Mpl |
Background: |
B6.129S1-Mpl |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd19/Cd19 Lyn/Lyn |
Background: |
involves: 129S4/SvJaeSor * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn Tg(Itgax-cre)1-1Reiz/? |
Background: |
involves: 129P2/OlaHsd * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn<+> |
Background: |
C57BL/6J-Lyn |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn<+> |
Background: |
C57BL/6J-Lyn |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Repeat |
Description: |
Phosphorylated immunoreceptor signalling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases []. Motif may be dually phosphorylated on tyrosine that links antigen receptors to downstream signalling machinery. |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn<+> Ptpn6/Ptpn6<+> Tg(IghelMD4)4Ccg/? |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Heiss E |
Year: |
2006 |
Journal: |
Blood |
Title: |
Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2. |
Volume: |
108 |
Issue: |
5 |
Pages: |
1542-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Malbec O |
Year: |
1998 |
Journal: |
J Immunol |
Title: |
Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation. |
Volume: |
160 |
Issue: |
4 |
Pages: |
1647-58 |
|
•
•
•
•
•
|
Allele |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 8.1, Shinichi Aizawa |
Allele Type: |
Targeted |
Attribute String: |
Reporter |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor |
Background: |
involves: C57BL/6NCrlj * CBA/JNCrlj |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd22/Cd22<+> Lyn/Lyn<+> Ptpn6/Ptpn6<+> Tg(IghelMD4)4Ccg/? |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Igh/Igh Lyn/Lyn |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Igh/Igh Lyn/Lyn |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn<+> |
Background: |
C57BL/6N-Lyn/H |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamabhai M |
Year: |
1997 |
Journal: |
Anal Biochem |
Title: |
Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins. |
Volume: |
247 |
Issue: |
1 |
Pages: |
143-51 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor |
Background: |
involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * FVB/N |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Fgr/Fgr Hck/Hck Lyn/Lyn |
Background: |
B6.Cg-Hck Fgr Lyn |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Lyn/Lyn Myd88/Myd88 Tg(Itgax-cre)1-1Reiz/? |
Background: |
involves: 129P2/OlaHsd * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Roifman CM |
Year: |
1993 |
Journal: |
Biochem Biophys Res Commun |
Title: |
CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells. |
Volume: |
194 |
Issue: |
1 |
Pages: |
222-5 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Lyn is a member of the Src non-receptor type tyrosine kinase family. It plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance [, ]. It also mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils [, , ]. Lyn plays an essential role in the transmission of signals through phosphorylation of tyrosine residues within the immunoreceptor tyrosine-based inhibitory motifs (ITIM) in regulatory proteins [, ].This entry represents the SH2 domain of Lyn.The Src non-receptor type tyrosine kinase (SFK) family members have an unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail. The SH2 domain of SFKs is involved in kinase autoinhibition and T-cell receptor signaling. The binding SH2 domains to phosphotyrosine (pY) sites is critical for the autoinhibition and substrate recognition of the SFKs []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Sampson M |
Year: |
2007 |
Journal: |
Front Biosci |
Title: |
Src kinases in G-CSF receptor signaling. |
Volume: |
12 |
|
Pages: |
1463-74 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) PTKs. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR []. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5 []. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules []. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). The SH3 domain of Src kinases contributes to substrate recruitment by binding adaptor proteins/substrates, and regulation of kinase activity through an intramolecular interaction [, ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Sparks AB |
Year: |
1996 |
Journal: |
Nat Biotechnol |
Title: |
Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins. |
Volume: |
14 |
Issue: |
6 |
Pages: |
741-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Okamoto M |
Year: |
2013 |
Journal: |
Nat Neurosci |
Title: |
TAG-1-assisted progenitor elongation streamlines nuclear migration to optimize subapical crowding. |
Volume: |
16 |
Issue: |
11 |
Pages: |
1556-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yoshioka H |
Year: |
2021 |
Journal: |
JBMR Plus |
Title: |
Single-Cell RNA-Sequencing Reveals the Breadth of Osteoblast Heterogeneity. |
Volume: |
5 |
Issue: |
6 |
Pages: |
e10496 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ainsua-Enrich E |
Year: |
2015 |
Journal: |
J Immunol |
Title: |
The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival. |
Volume: |
194 |
Issue: |
9 |
Pages: |
4309-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hatani T |
Year: |
2008 |
Journal: |
Curr Med Chem |
Title: |
Adaptor protein 3BP2 and cherubism. |
Volume: |
15 |
Issue: |
6 |
Pages: |
549-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Levaot N |
Year: |
2011 |
Journal: |
Cell |
Title: |
Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. |
Volume: |
147 |
Issue: |
6 |
Pages: |
1324-39 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qu X |
Year: |
2005 |
Journal: |
Biochemistry |
Title: |
Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor. |
Volume: |
44 |
Issue: |
10 |
Pages: |
3891-8 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
45
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
The adaptor protein 3BP2/SH3BP2 is a cytoplasmic adaptor that contributes to the regulation of immune responses []. The protein-tyrosine kinase Syk phosphorylates 3BP2 which results in the activation of Rac1 through the interaction with the SH2 domain of Vav1 and induces the binding to the SH2 domain of the upstream protein-tyrosine kinase Lyn and enhances its kinase activity []. 3BP2 has a positive regulatory role in IgE-mediated mast cell activation []. In lymphocytes, engagement of T cell or B cell receptors triggers tyrosine phosphorylation of 3BP2 []. 3BP2 is required for the proliferation of B cells and B cell receptor signaling. Mutations in the 3BP2 gene are responsible for cherubism resulting in excessive bone resorption in the jaw [].This entry represents the SH2 domain of SH3BP2. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The adaptor protein 3BP2/SH3BP2 is a cytoplasmic adaptor that contributes to the regulation of immune responses []. The protein-tyrosine kinase Syk phosphorylates 3BP2 which results in the activation of Rac1 through the interaction with the SH2 domain of Vav1 and induces the binding to the SH2 domain of the upstream protein-tyrosine kinase Lyn and enhances its kinase activity []. 3BP2 has a positive regulatory role in IgE-mediated mast cell activation []. In lymphocytes, engagement of T cell or B cell receptors triggers tyrosine phosphorylation of 3BP2 []. 3BP2 is required for the proliferation of B cells and B cell receptor signaling. Mutations in the 3BP2 gene are responsible for cherubism resulting in excessive bone resorption in the jaw []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Takemoto Y |
Year: |
1998 |
Journal: |
J Immunol |
Title: |
Growth factor receptor-bound protein 2 (Grb2) association with hemopoietic specific protein 1: linkage between Lck and Grb2. |
Volume: |
161 |
Issue: |
2 |
Pages: |
625-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
De S |
Year: |
2015 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signal. |
Volume: |
112 |
Issue: |
31 |
Pages: |
9680-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ingley E |
Year: |
2008 |
Journal: |
Biochim Biophys Acta |
Title: |
Src family kinases: regulation of their activities, levels and identification of new pathways. |
Volume: |
1784 |
Issue: |
1 |
Pages: |
56-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Engen JR |
Year: |
2008 |
Journal: |
Cell Mol Life Sci |
Title: |
Structure and dynamic regulation of Src-family kinases. |
Volume: |
65 |
Issue: |
19 |
Pages: |
3058-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lynch DT |
Year: |
2002 |
Journal: |
J Gen Virol |
Title: |
Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells. |
Volume: |
83 |
Issue: |
Pt 5 |
Pages: |
1025-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rovedo M |
Year: |
2007 |
Journal: |
J Virol |
Title: |
Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity. |
Volume: |
81 |
Issue: |
1 |
Pages: |
84-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rancan C |
Year: |
2015 |
Journal: |
PLoS Pathog |
Title: |
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells. |
Volume: |
11 |
Issue: |
6 |
Pages: |
e1004906 |
|
•
•
•
•
•
|
Publication |
First Author: |
Geimonen E |
Year: |
2003 |
Journal: |
J Virol |
Title: |
Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. |
Volume: |
77 |
Issue: |
2 |
Pages: |
1638-43 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Signal transduction by T and B cell antigen receptors and certain receptorsfor Ig Fc regions involves a conserved sequence motif, termed animmunoreceptor tyrosine-based activation motif (ITAM). It is also found in thecytoplasmic domain of the apoptosis receptor. Phosphorylation of the two ITAMtyrosines is a critical event in signal transduction. All (p)2ITAMs, but nottheir nonphosphorylated counterparts, induced extensive protein tyrosinephosphorylation in permeabilised cells. After binding of the ligand via an SH2domain, phosphorylation of the two conserved tyrosines of ITAM creates binding sites for downstream signalling molecules and thus enables the initiation of signalling events. This phosphorylation was found to reflect activation of the src family kinases Lyn and Syk. Different ITAMs may preferentially activate distinct signalling pathways as a consequence of distinct SH2 effector binding preference [, ]. Furthermore, in viruses, ITAMs may play key roles in viral pathogenesis by regulating viral clearance, immune cell activation, immune cell recruitment through binding of cellular kinases and thereby down regulate their function [].This motif can be found in one to three copies and in association with the Ig-like domain. Proteins currently known to contain an ITAM motif are:Mammalian alpha and beta immunoglobulin proteins, TCR gamma receptors, FCR gamma receptors subunits, CD3 chains receptors and NFAT activation molecule.Hantavirus cytoplasmic elements. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This family consists of several Gammaherpesvirus latent membrane protein (LMP2) proteins. Epstein-Barr virus (strain GD1) (HHV-4) (Human herpesvirus 4) is a human gammaherpesvirus that infects and establishes latency in B lymphocytes in vivo. The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. LMP2A is thought to play a key role in either the establishment or the maintenance of latency and/or the reactivation of productive infection from the latent state. It modulates B-cell receptor signal transduction through its association with the cellular tyrosine kinases Lyn and Syk via specific motifs at the N-terminal tail domain. LMP2A also modulates the immune system reducing infected B cells recognition by EBV-specific CD8+ T cells []. The significance of LMP2B and its role in pathogenesis remain unclear. It is suggested that it may be a negative regulator of LMP2A [, ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Lowell CA |
Year: |
1994 |
Journal: |
Genes Dev |
Title: |
Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity. |
Volume: |
8 |
Issue: |
4 |
Pages: |
387-98 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kraus M |
Year: |
2001 |
Journal: |
J Exp Med |
Title: |
Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail. |
Volume: |
194 |
Issue: |
4 |
Pages: |
455-69 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cheng D |
Year: |
2017 |
Journal: |
Nat Immunol |
Title: |
Themis2 lowers the threshold for B cell activation during positive selection. |
Volume: |
18 |
Issue: |
2 |
Pages: |
205-213 |
|
•
•
•
•
•
|
Publication |
First Author: |
Grimmler M |
Year: |
2007 |
Journal: |
Cell |
Title: |
Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. |
Volume: |
128 |
Issue: |
2 |
Pages: |
269-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rahaman SO |
Year: |
2006 |
Journal: |
Cell Metab |
Title: |
A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. |
Volume: |
4 |
Issue: |
3 |
Pages: |
211-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Thim-Uam A |
Year: |
2020 |
Journal: |
iScience |
Title: |
STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation. |
Volume: |
23 |
Issue: |
9 |
Pages: |
101530 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kin NW |
Year: |
2007 |
Journal: |
J Immunol |
Title: |
CD86 regulates IgG1 production via a CD19-dependent mechanism. |
Volume: |
179 |
Issue: |
3 |
Pages: |
1516-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Weber M |
Year: |
2008 |
Journal: |
J Exp Med |
Title: |
Phospholipase C-gamma2 and Vav cooperate within signaling microclusters to propagate B cell spreading in response to membrane-bound antigen. |
Volume: |
205 |
Issue: |
4 |
Pages: |
853-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu JL |
Year: |
2017 |
Journal: |
Nat Commun |
Title: |
O-GlcNAcylation is required for B cell homeostasis and antibody responses. |
Volume: |
8 |
Issue: |
1 |
Pages: |
1854 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hao JW |
Year: |
2020 |
Journal: |
Nat Commun |
Title: |
CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis. |
Volume: |
11 |
Issue: |
1 |
Pages: |
4765 |
|
•
•
•
•
•
|
Publication |
First Author: |
Heyer J |
Year: |
1997 |
Journal: |
Immunobiology |
Title: |
Inefficient termination of antigen responses in NF-ATp-deficient mice. |
Volume: |
198 |
Issue: |
1-3 |
Pages: |
162-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang J |
Year: |
2022 |
Journal: |
iScience |
Title: |
Na/K-ATPase suppresses LPS-induced pro-inflammatory signaling through Lyn. |
Volume: |
25 |
Issue: |
9 |
Pages: |
104963 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang J |
Year: |
2006 |
Journal: |
Cancer Cell |
Title: |
Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies. |
Volume: |
10 |
Issue: |
4 |
Pages: |
295-307 |
|
•
•
•
•
•
|
Publication |
First Author: |
Caldwell RG |
Year: |
1998 |
Journal: |
Immunity |
Title: |
Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. |
Volume: |
9 |
Issue: |
3 |
Pages: |
405-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kitaura J |
Year: |
2005 |
Journal: |
Blood |
Title: |
IgE- and IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion. |
Volume: |
105 |
Issue: |
8 |
Pages: |
3222-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fujimoto M |
Year: |
2000 |
Journal: |
Immunity |
Title: |
CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. |
Volume: |
13 |
Issue: |
1 |
Pages: |
47-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu J |
Year: |
2007 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Synthetic glycan ligand excludes CD22 from antigen receptor-containing lipid rafts. |
Volume: |
360 |
Issue: |
4 |
Pages: |
759-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rub A |
Year: |
2009 |
Journal: |
Nat Immunol |
Title: |
Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. |
Volume: |
10 |
Issue: |
3 |
Pages: |
273-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu R |
Year: |
2018 |
Journal: |
J Clin Invest |
Title: |
MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. |
Volume: |
128 |
Issue: |
6 |
Pages: |
2551-2568 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hayashi S |
Year: |
2014 |
Journal: |
Dev Cell |
Title: |
Protocadherin-17 mediates collective axon extension by recruiting actin regulator complexes to interaxonal contacts. |
Volume: |
30 |
Issue: |
6 |
Pages: |
673-87 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
86
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
164
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
177
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
189
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
188
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Kishi K |
Year: |
2021 |
Journal: |
Genesis |
Title: |
Repetitive short-pulsed illumination efficiently activates photoactivatable-Cre as continuous illumination in embryonic stem cells and pre-implantation embryos of transgenic mouse. |
Volume: |
59 |
Issue: |
12 |
Pages: |
e23457 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cheng PC |
Year: |
1999 |
Journal: |
J Exp Med |
Title: |
A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. |
Volume: |
190 |
Issue: |
11 |
Pages: |
1549-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cheng PC |
Year: |
2001 |
Journal: |
J Immunol |
Title: |
Translocation of the B cell antigen receptor into lipid rafts reveals a novel step in signaling. |
Volume: |
166 |
Issue: |
6 |
Pages: |
3693-701 |
|
•
•
•
•
•
|
Publication |
First Author: |
Draber P |
Year: |
2011 |
Journal: |
Mol Cell Biol |
Title: |
SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling. |
Volume: |
31 |
Issue: |
22 |
Pages: |
4550-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Akimoto M |
Year: |
2009 |
Journal: |
Scand J Immunol |
Title: |
Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses. |
Volume: |
69 |
Issue: |
5 |
Pages: |
401-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang D |
Year: |
2010 |
Journal: |
FASEB J |
Title: |
Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1. |
Volume: |
24 |
Issue: |
3 |
Pages: |
947-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang L |
Year: |
2002 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Identification and genetic analysis of human and mouse activated Cdc42 interacting protein-4 isoforms. |
Volume: |
293 |
Issue: |
5 |
Pages: |
1426-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu H |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. |
Volume: |
278 |
Issue: |
13 |
Pages: |
11520-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mao H |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen. |
Volume: |
8 |
Issue: |
6 |
Pages: |
e68143 |
|
•
•
•
•
•
|
Publication |
First Author: |
Watanabe M |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Overproduction of IgE induces macrophage-derived chemokine (CCL22) secretion from basophils. |
Volume: |
181 |
Issue: |
8 |
Pages: |
5653-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hochgräfe F |
Year: |
2010 |
Journal: |
Cancer Res |
Title: |
Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. |
Volume: |
70 |
Issue: |
22 |
Pages: |
9391-401 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang J |
Year: |
2023 |
Journal: |
Biochem Pharmacol |
Title: |
Macrophage scavenger receptor A1 antagonizes abdominal aortic aneurysm via upregulating IRG1. |
Volume: |
213 |
|
Pages: |
115631 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsubara T |
Year: |
2021 |
Journal: |
J Biol Chem |
Title: |
Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation. |
|
|
Pages: |
100790 |
|
•
•
•
•
•
|